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Background: High salt intake in patients with chronic kidney disease (CKD) may cause high blood pressure and
increased albuminuria. Although, the estimation of salt intake is essential, there are no easy methods to estimate
real salt intake.
Methods: Salt intake was assessed by determining urinary sodium excretion from the collected urine samples.
Estimation of salt intake by spot urine was calculated by Tanaka’s formula. The correlation between estimated and
measured sodium excretion was evaluated by Pearson´s correlation coefficients. Performance of equation was
estimated by median bias, interquartile range (IQR), proportion of estimates within 30% deviation of measured
sodium excretion (P30) and root mean square error (RMSE).The sensitivity and specificity of estimated against
measured sodium excretion were separately assessed by receiver-operating characteristic (ROC) curves.
Results: A total of 334 urine samples from 96 patients were examined. Mean age was 58 ± 16 years, and estimated
glomerular filtration rate (eGFR) was 53 ± 27 mL/min. Among these patients, 35 had CKD stage 1 or 2, 39 had stage
3, and 22 had stage 4 or 5. Estimated sodium excretion significantly correlated with measured sodium excretion
(R = 0.52, P < 0.01). There was apparent correlation in patients with eGFR <30 mL/min (R = 0.60, P < 0.01). Moreover,
IQR was lower and P30 was higher in patients with eGFR < 30 mL/min. Estimated sodium excretion had high
accuracy to predict measured sodium excretion, especially when the cut-off point was >170 mEq/day (AUC 0.835).
Conclusions: The present study demonstrated that spot urine can be used to estimate sodium excretion, especially
in patients with low eGFR.
Keywords: Chronic kidney disease, Salt intake, Urinary sodium excretionBackground
Chronic kidney disease (CKD) is characterized by hyperten-
sion, which is thought to be predominately salt sensitive [1].
High salt intake in CKD patients may cause high blood
pressure, increased albuminuria and increased filtration
fraction [2–7]. Salt restriction can result in diminished
albuminuria and preservation of renal function [8–10]. The
INTERSALT study [11] estimated salt intake by 24 h urine
collection at 52 centers in 32 countries, and showed that
the mean daily salt intake was 9.2 g. However, the average
estimated salt intake by 24 h urine collection obtained from
3 Japanese centers was 11.0 g, suggesting that the Japanese
have a relatively higher than average salt intake. The major* Correspondence: mogura@jikei.ac.jp
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reproduction in any medium, provided the ormethods in current use for assessment salt intake are diet-
ary recall and 24 h urine sodium excretion measurement.
Dietary recall is often inaccurate, and many patients are
truly unaware of the amount of sodium they consume.
Measurement of 24 h urine sodium excretion is considered
to be reliable, and has been used in many clinical and epi-
demiological studies, including the INTERSALT study.
However, it is relatively difficult to perform because of the
necessity of 24 h urine sampling, and inadequate urine
pooling leads to under- or over-estimation of salt intake.
The use of a spot urine method, or a brief timed collection,
for assessing sodium excretion has previously been exam-
ined [12–14]. Tanaka et al. [12] developed a simple method
to estimate 24 h urinary sodium excretion from spot urine
specimens collected at any time, using 591 Japanese data
items from the INTERSALT study. Estimated sodiumtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Clinical characteristics
Characteristics n = 96
Age (years) 58 ± 16
Gender (male, %) 47 (49)
Cr (mg/dL) 1.4 ± 1.0
eGFR (mL/min) 53 ± 27
CKD stage (n, %)
stage 1,2 35 (36.5)
stage 3 39 (40.6)
stage 4,5 22 (22.9)
UPR (g/d) 1.2 ± 1.4
Urine volume (mL/d) 1889 ± 547
eGFR: estimated glomerular filtration rate, UPR: urinary protein excretion.
Ogura et al. BMC Nephrology 2012, 13:36 Page 2 of 7
http://www.biomedcentral.com/1471-2369/13/36excretion was significantly correlated with measured
sodium excretion using 24 h urine collection among these
populations. There have been few reports about estimated
salt intake in patients with a decline in renal function. The
purpose of the present study was to evaluate whether the
estimation of salt intake from spot urine could predict real
salt intake in patients with CKD.
Methods
A total of 100 CKD subjects were recruited from the
outpatient department of The Jikei University Kashiwa
Hospital between October 2009 and May 2010. All
patients were requested to collect urine for 24 h. Salt in-
take was assessed by determining urinary sodium excre-
tion from the collected urine samples. Furthermore, spot
urine samples were examined on the same day that
patients brought their 24 h urine samples to the hospital.
These measurements were performed at least twice during
the study period. We also measured urinary creatinine
(Cr) excretion using 24 h urine samples. Data were
excluded when urinary Cr excretion <1000, >2500 mg/day
for male and <600, >1500 mg/day for female considering
inadequate urine collection [15]. Four patients were
excluded because of inadequate collection of urine.
Estimation of sodium excretion by spot urine was calcu-
lated by Tanaka’s method, using the following formula [12].
24 h Na excretion mEq=dð Þ
¼ 21:98 f Na S=ðCr S 10Þ½   Pr:UCr24 g0:392
Na S : Na concentration in spot urine mEq=Lð Þ
Cr S : Cr concentration in spot urine mg=dLð Þ
Pr:UCr24 : predicted value of 24 h urinary Cr excretion mg=dð Þ
¼ 2:04 Age yearsð Þ þ 14:89 Bodyweight kgð Þ
þ16:14Height cmð Þ  2244:45
Briefly, 24 h sodium excretion (24HUNaV) (mEq/day)
was estimated by the formula as follows; 21.98×XNa0.392
(XNa=Na concentration in the spot urine / creatinine
concentration in the spot urine × predicted value of 24 h
urinary Cr excretion (Pr.UCr24)). This formula including
constant was obtained using 591 Japanese data items from
the INTERSALT study.
Estimated values of urinary sodium excretion calculated
using spot urine were compared to sodium excretion
assessed by 24 h urine samples. The correlation between
estimated and measured sodium excretion was evaluated
by univariate analysis. The values of salt intake were calcu-
lated from urinary sodium excretion by standard method
(1 mEq of sodium=58.5 mg of NaCl). Correlations
between estimated and measured sodium excretion were
evaluated by Pearson´s correlation coefficients. The me-
dian difference between measured and estimated sodium
excretion was used to calculate the bias. Precision of the
estimates was expressed by interquartile range (IQR). Ac-
curacy was measured as the proportion of estimates within30% deviation of measured sodium excretion (P30). Accur-
acy was also expressed in terms of the root mean square
error (RMSE). The Bland-Altman Plot was used to esti-
mate the bias and limits of agreement between measure-
ments by the two methods. To analyze the sensitivity and
specificity of estimated sodium excretion in relationship to
measured sodium excretion, receiver-operating character-
istic (ROC) curves were generated, including area under
the curve (AUC) and their 95% confidence intervals (CI).
The sensitivity and specificity of estimated against mea-
sured sodium excretion were separately assessed by two
cut-off points (>170 and >100 mEq/day, respectively).
The protocol was in conformity with institutional ethical
guidelines (The Ethical Committee of The JIkei university
school of medicine) and informed consent was obtained
from each participant. Data were analyzed by using SPSS
17.0 (SPSS Inc, Chicago, IL), Bland-Altman with MedCalc
software (version 12.1.4.0; Mariakerke Belgium). The
P values reported are 2-sided and were taken to be statisti-
cally significant at 0.05.Results
Table 1 shows the characteristics of patients. Mean age
was 58±16 years and 49% of the patients were men. Mean
serum Cr was 1.4± 1.0 mg/dL and estimated glomerular
filtration rate (eGFR) was 53± 27 mL/min. Among these
patients, 35 had stage 1 or 2 CKD (36.5%), 39 had stage 3
CKD (40.6%), and 22 had stage 5 CDK (22.9%). Mean urin-
ary protein excretion was 1.2± 1.4 g/day.
A total of 334 samples from 96 patients were exam-
ined. Figure 1 shows the correlation between estimated
sodium excretion by spot urine and measured sodium
excretion assessed by 24 h urine sampling. Estimated so-
dium excretion significantly correlated with measured
sodium excretion (R = 0.52, P < 0.01). Figure 2 demon-







































Estimated sodium excretion by spot urine (mEq/day) 
R=0.52  P<0.01
Figure 1 Correlation between estimated sodium excretion by spot urine and measured sodium excretion assessed by 24 h urinary
samples. Estimated sodium excretion significantly correlated with measured sodium excretion (R = 0.52, P < 0.01).
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lations were recognized between estimated and mea-
sured sodium excretion in patients with eGFR >60 and
30-60 mL/min (R = 0.52, P < 0.01 and R= 0.47, P < 0.01,
respectively). There was apparent correlation in patients





















































Figure 2 Correlation between estimated sodium excretion and measu
were recognized between estimated and measured sodium excretion in pa
R = 0.47, P < 0.01, respectively). There was apparent correlation in patients wFigure 3 shows Bland-Altman analysis of the differ-
ences between estimated and measured sodium excretion
compared to the average sodium excretion by the two
methods. The mean difference was -10.9 (central line). A
total of 94% (90 of 96) of the values lie within 1.96 SDs
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Figure 3 Bland-Altman analysis of the differences between estimated and measured sodium excretion compared to the average
sodium excretion by the two methods. The mean difference was -10.9 (central line). A total of 94% (90 of 96) of the values lie within 1.96 SDs
of the mean (outer lines).
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estimating equation in patients with CKD. Median bias
was 4.5 and percentage bias was 2.7%. IQR, an indicator
of precision, was 53 mEq/ day. RMSE and P30, an indi-
cator of accuracy, were 50 mEq/ day and 70%, respect-
ively in overall patients. For each of the eGFR equations,
the dataset was split into 3 groups: eGFR <30, 30–60,
and >60 mL/min. Median bias and IQR were lower in
patients with eGFR< 30 mL/min. Moreover, RMSE was
lower and P30 was higher in patients at lower levels of
eGFR (Table 2, Figure 4).
Finally, AUC values of estimated sodium excretion for
predicting measured sodium excretion were examined by
ROC curves. As shown in Figure 5, the AUC values were
0.835 and 0.719, respectively, when the cut-off point was
>170 mEq/day and >100 mEq/day. Estimated sodium ex-
cretion had high accuracy to predict measured sodium
excretion, especially when the cut-off point
was >170 mEq/day.Table 2 Performance of urinary sodium estimating equation
eGFR n Median bias Median per
mL/min (95% CI) %
eGFR <30 22 0.0 (-14.2-24.1) 0.0
eGFR 30-60 39 9.0 (-1.0-19.4) 5.9
eGFR >60 35 -2.0 (-5.8-16.3) -1.3
Overall 96 4.5 (-2.1-12.2) 2.7
eGFR: estimated glomerular filtration rate, IQR: interquartile range, RMSE: root mean
measured sodium intake.Discussions
The present study indicated that estimated sodium
excretion from spot urine collected from CKD patients
had adequate value for prediction of measured sodium
excretion from 24 h urine collection. The use of a spot
urine method or another brief timed collection for
assessment of sodium excretion has previously been
examined [12–14]. Kamata et al. [13] predicted 24 h so-
dium excretion using overnight urine by pipe-sampling
method. Pr.UCr24 was estimated from lean body mass.
Sodium excretion in nighttime urine has been reported
to be relatively close agreement with the value deter-
mined in 24 h urine collection. Kawasaki et al. [14]
estimated urinary sodium excretion, using Na/Cr con-
centrations in the second urine sample collected after
waking. An estimate of Pr.UCr24 can be calculated from
a formula height, body weight and age. However, its clin-
ical use may be limited because second urine sampling































Figure 4 Accuracy and precision of estimates expressed as P30 and IQR categorized by eGFR. Highest accuracy within 30% and lowest
precision were found for samples with an eGFR <30 mL/min. P30: percentage of estimated sodium intake within 30% of measured sodium intake,
IQR: interquartile range.
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http://www.biomedcentral.com/1471-2369/13/36Estimation of salt intake using a spot urine sample col-
lected at any time would be much easier to perform. Un-
fortunately, the spot urine Na/Cr ratio has inherent
limitations in estimating 24 h sodium excretion because
sodium excretion varies considerably from hour to hour.
And, the accuracy of predicting 24 h sodium excretion is
altered by interindividual differences in 24 h creatinine
excretion. Tanaka et al. [12] reported a simple method
that can be used to estimate 24 h urinary sodium excre-




















Figure 5 ROC curves, including area under the curve (AUC). The sensit
sodium excretion was separately assessed by two cut-off points (>170 and
accuracy to predict measured sodium excretion using AUC, especially when
sodium excretion.time using 591 Japanese data items from the INTER-
SALT study. Estimated sodium excretion calculated by
the formulas shown in Table 1 significantly correlated
with measured sodium excretion using 24 h urine collec-
tion among the population (R = 0.54, P < 0.01). They also
performed an additional validity examination using
external 513 people who did not participate in the
INTERSALT study. Consequently, they reported that the
difference between measured and estimated values was




















ivity and specificity of estimated sodium excretion against measured
>100 mEq/day, respectively). Estimated sodium excretion had high
the cut-off point was >170 mEq/day (AUC 0.835). UNa: urinary
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nonetheless considered to be useful to estimate sodium ex-
cretion of subjects with relatively high salt intake, because
the differences were smaller in the quintile groups with
larger amounts of sodium excretion.
In the present data, using Tanaka’s method, estimated
sodium excretion significantly correlated with measured
sodium excretion (R = 0.52, P < 0.01). Such correlation
coefficient was nearly the same as Tanaka’s data. Patients
with a low eGFR (stage 4 and 5 CKD) had a relatively
stronger correlation (R = 0.60, P < 0.01) than patients
with a moderate to high eGFR. Moreover, the assess-
ments of performance for urinary sodium equation
demonstrated that median bias and IQR were lower in
patients with eGFR < 30 mL/min. Accuracy, which were
estimated by RMSE and P30, were higher in patients at
lower levels of eGFR. These results indicated Tanaka’s
method had higher predictive value especially in low
eGFR patients with CKD.
Sodium excretion exhibits a diurnal rhythm. In the
general population, sodium excretion during the night-
time has been reported to be 20% lower than during the
daytime [16,17]. Moreover, sodium excretion was
reported to be higher in the afternoon than in the morn-
ing [18]. Several studies have demonstrated that the 24 h
Na/Cr ratio was markedly correlated with the spot urine
Na/Cr ratio obtained in the late afternoon, not in the
morning [19,20]. In the present study, most of the spot
urine samples were collected in the morning. The mod-
erate correlation between measured and estimated so-
dium excretion (R = 0.52) was probably due to the
difference of the time to submit spot urine. Fukuda et al.
[21] investigated the impact of renal function on the
night/day ratio of blood pressure and urinary water and
electrolyte excretion. They demonstrated in patients with
glomerulopathy that as renal function deteriorated, noc-
turnal blood pressure elevated and urinary excretion
rates of sodium and protein were enhanced during the
night. The present study revealed that estimated sodium
excretion tended to have a higher accuracy to assess
measured (real) salt intake in patients with a low eGFR.
Considering these findings, the low eGFR could have
muted the diurnal fluctuation of sodium excretion, and
stabilized the predicted value.
Finally, the sensitivity and specificity of estimated so-
dium excretion were analyzed in relationship to mea-
sured sodium excretion with two cut-off points (>170
and >100 mEq/day). International recommendations sug-
gest that the salt intake of the general population should
be less than 5-6 g (100 mEq)/day [22,23]. On the other
hand, while salt intake in Japan is decreasing, it is still
high, at about 11 g/day. Kuriyama et al reported
reduction in salt intake from 11-14 g/day to 7-8 g/day
led to a significant decrease in daily protein excretion in51 Japanese CKD patients [10]. Swift et al reported that
reducing salt intake from 170 mEq/gay to 89 mEq/day
reduced blood pressure and urine protein excretion in
black hypertensives [24]. Considering these findings, the
two cut-off points were set at >170 mEq (10 g) /day
and >100 mEq (6 g) /day. Estimated sodium excretion
using spot urine had high accuracy to predict measured
sodium excretion when the cut-off point was >170 mEq/
day (AUC: 0.835). These results agreed with Tanaka’s
assessment that the equation was considered to be useful
to estimate sodium excretion of subjects with relatively
high salt intake.
There were some limitations in the present study. The
number of patients recruited was relatively small. More-
over, number of patients with a low eGFR (stage 4 and 5
CKD) was smaller than patients with a moderate or high
eGFR (stage 1 to 3 CKD). Further studies with larger
numbers of patients allocated equally by eGFR may be
needed to clarify these issues.
Conclusions
The present study demonstrated that salt intake could be
estimated by spot urine samples, especially in CKD
patients with relatively high salt intake and with a low
eGFR. Although measurement of 24 h urine sodium
excretion is considered the gold standard, assessment of
salt intake in spot urine samples could be applied, in
part, for management of patients with CKD.
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